KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Current Taxes (2023 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Current Taxes for 3 consecutive years, with $313000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Current Taxes fell 94.5% to $313000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $313000.0, a 94.5% decrease, with the full-year FY2025 number at $313000.0, down 94.5% from a year prior.
  • Current Taxes was $313000.0 for Q4 2025 at Xenon Pharmaceuticals, up from $231000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $6.6 million in Q1 2025 to a low of $231000.0 in Q3 2025.
  • A 3-year average of $2.5 million and a median of $1.1 million in 2023 define the central range for Current Taxes.
  • Peak YoY movement for Current Taxes: soared 1538.62% in 2024, then crashed 94.5% in 2025.
  • Xenon Pharmaceuticals' Current Taxes stood at $347000.0 in 2023, then skyrocketed by 1538.62% to $5.7 million in 2024, then plummeted by 94.5% to $313000.0 in 2025.
  • Per Business Quant, the three most recent readings for XENE's Current Taxes are $313000.0 (Q4 2025), $231000.0 (Q3 2025), and $1.8 million (Q2 2025).